Senti Biosciences, Inc.
SNTI
$2.10
$0.041.94%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -18.13M | -14.73M | -14.11M | -610.00K | -28.87M |
| Total Depreciation and Amortization | 904.00K | 914.00K | 926.00K | 1.46M | 946.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.55M | 1.57M | 1.20M | -12.89M | 16.47M |
| Change in Net Operating Assets | 6.23M | -819.00K | -2.07M | -1.46M | 3.58M |
| Cash from Operations | -9.45M | -13.07M | -14.05M | -13.50M | -7.87M |
| Capital Expenditure | 0.00 | -196.00K | -- | -11.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 12.00K | -- | 0.00 | 60.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -184.00K | -- | -11.00K | 60.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 136.00K | 534.00K | -- | 49.05M | 10.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.00K | 477.00K | -414.00K | 2.24M | 2.43M |
| Cash from Financing | 124.00K | 1.01M | -414.00K | 51.29M | 2.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.32M | -12.25M | -14.46M | 37.78M | -5.37M |